SandsRx Pharmacy
- Company typePrivate
- Founded2013
- HeadquartersWylie, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
SandsRx Pharmacy firmographics
Firmographics- Name
- SandsRx Pharmacy
- Website
- https://sandsrx.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Where SandsRx Pharmacy is headquartered
LocationHeadquarters
- HQ city
- Wylie
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
SandsRx Pharmacy business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D
Revenue model
- Compounding Pharmacy Services: Revenue generated from providing PCAB-accredited sterile and non-sterile compounding services for personalized medicine formulations in dermatology, urology, weight management, and hormone replacement therapy.
Distribution channels1 record
SandsRx Pharmacy product offering
Product offeringCore offering
SandsRx Pharmacy operates PCAB-accredited sterile and non-sterile compounding services from state-of-the-art facilities in Wylie and Frisco, Texas, maintaining USP <795> and <797> compliance. It produces personalized compounded medications across therapeutic areas including dermatology, urology, weight management, and hormone replacement therapy, distributing formulations via its strategic partnership with the eNavvi digital prescription marketplace.
Product overview
SandsRx Pharmacy is a premier independent pharmacy based in Texas operating state-of-the-art facilities in Wylie and Frisco. The company offers a unified portfolio of PCAB-accredited compounding services, encompassing both sterile and non-sterile preparations. The core product lines include specialized formulations across dermatology, urology, weight management, and hormone replacement therapy, all maintained in compliance with USP <795> and <797> compounding standards. The services are delivered through a strategic partnership with eNavvi's digital prescription marketplace, which provides prescribers with streamlined access to these specialized formulations.
Differentiator
Problem solved
Functional benefit
Products and services
- PCAB-Accredited Sterile Compounding Services
Companies that use SandsRx Pharmacy
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles2 records
SandsRx Pharmacy technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature2 records
SandsRx Pharmacy partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- eNavvicoreeNavvi, a digital prescription marketplace, announced a strategic partnership with SandsRx to expand access to PCAB-accredited sterile and non-sterile compounding services. The collaboration provides prescribers with streamlined access to specialized formulations for dermatology, urology, weight management, and hormone replacement therapy, addressing growing demand for personalized medicine.
Scale indicators2 records
Recent moves3 records
Expansion highlights3 records
SandsRx Pharmacy competitors and assessment
Company assessmentBroad incumbents
- Fagron: Global leader in pharmaceutical compounding supplying APIs, excipients, bases, and equipment to compounding pharmacies worldwide. Comparable through shared compounding-pharmacy end market, but operates as an upstream supplier and compounder rather than a US-dispensing pharmacy.
- Avella Specialty Pharmacy: National specialty pharmacy offering compounding along with broader specialty drug dispensing and clinical services. Comparable in compounding and specialty therapeutic mix, but materially larger and broader in service portfolio.
Direct peers
- Wedgewood Pharmacy: One of the largest US compounding pharmacies, offering sterile and non-sterile preparations across multiple specialties including veterinary, dermatology, and hormone therapy. Closely comparable to SandsRx in service breadth and emphasis on personalized formulations.
- Empower Pharmacy: Large independent compounding pharmacy with both 503A and 503B registrations, producing sterile injectables, hormone therapies, and dermatology preparations. Comparable in compounding breadth and sterility capability, though larger in scale.
- Koshland Pharmacy: Independent custom compounding pharmacy in California offering personalized medications in dermatology, hormone therapy, and pediatrics. Comparable in scale, independent ownership, and customization-led value proposition.
- Wells Pharmacy Network: Specialty compounding pharmacy operating both 503A and 503B facilities, producing sterile and non-sterile preparations for providers nationwide. Comparable sterile compounding capabilities and prescriber-led distribution model.
- Curexa Pharmacy: Specialty compounding pharmacy offering customized sterile and non-sterile preparations for dermatology, women's health, pediatrics, and other specialties. Directly comparable in therapeutic verticals and compounding-pharmacy operating model.
- Innovation Compounding: Independent compounding pharmacy providing sterile and non-sterile preparations for hormone replacement therapy, dermatology, weight management, and pain management. Directly comparable therapeutic mix and accreditation-driven positioning.
- AnazaoHealth: Compounding pharmacy serving patients and providers with sterile and non-sterile preparations across multiple therapeutic areas including HRT and men's/women's health. Directly comparable service profile and B2B prescriber focus.
Others
- Professional Compounding Centers of America (PCCA): Industry resource and supplier providing APIs, bases, training, and technical support to independent compounding pharmacies. Adjacent enabler of the compounding pharmacy category in which SandsRx operates.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
SandsRx Pharmacy social profiles
Digital presenceSandsRx Pharmacy compliance and trust
Trust signalCompliance3 records
SandsRx Pharmacy financial estimates
Financial estimateRevenue estimate
Valuation estimate
SandsRx Pharmacy leadership team
Management profileNumber of profiles
SandsRx Pharmacy funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SandsRx Pharmacy M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SandsRx Pharmacy
What does SandsRx Pharmacy do?
SandsRx Pharmacy operates PCAB-accredited sterile and non-sterile compounding services from state-of-the-art facilities in Wylie and Frisco, Texas, maintaining USP <795> and <797> compliance. It produces personalized compounded medications across therapeutic areas including dermatology, urology, weight management, and hormone replacement therapy, distributing formulations via its strategic partnership with the eNavvi digital prescription marketplace.
When was SandsRx Pharmacy founded?
SandsRx Pharmacy was founded in 2013. It employs 11 to 50 people.
Where is SandsRx Pharmacy based?
SandsRx Pharmacy is headquartered in Wylie, United States, in the North America region.
How does SandsRx Pharmacy make money?
One revenue line is on record: compounding Pharmacy Services.
Who are SandsRx Pharmacy's main competitors?
Broad incumbents on record are Fagron and Avella Specialty Pharmacy. Direct peers are Wedgewood Pharmacy, Empower Pharmacy, Koshland Pharmacy, Wells Pharmacy Network, Curexa Pharmacy, Innovation Compounding and AnazaoHealth. Professional Compounding Centers of America (PCCA) is listed as an others.
Does SandsRx Pharmacy have an API?
No public API is recorded for SandsRx Pharmacy.